Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - DEPRECIATION & AMORTIZATION
Depreciation & Amortization GLUE - Monte Rosa Therapeutics, Inc.
8.12 M
LAST VALUE
47.26%
2 YEAR CAGR
157.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR